Detalles de la búsqueda
1.
Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial.
Lancet Oncol
; 25(1): 108-116, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070530
2.
Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients.
Breast Cancer Res Treat
; 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38709373
3.
Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015).
Breast Cancer Res
; 25(1): 39, 2023 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046348
4.
Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study.
Breast Cancer Res
; 24(1): 61, 2022 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096872
5.
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.
Mod Pathol
; 35(10): 1362-1369, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35729220
6.
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
Lancet
; 395(10218): 117-122, 2020 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31839281
7.
Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer.
Breast Cancer Res Treat
; 186(1): 115-123, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33222093
8.
Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Breast Cancer Res Treat
; 190(2): 295-305, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34524591
9.
A simple digital image analysis system for automated Ki67 assessment in primary breast cancer.
Histopathology
; 79(2): 200-209, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33590538
10.
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial.
Lancet Oncol
; 21(11): 1443-1454, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152284
11.
Correction to: Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
Breast Cancer Res
; 22(1): 14, 2020 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32005287
12.
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
N Engl J Med
; 377(19): 1836-1846, 2017 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29117498
13.
Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
Breast Cancer Res
; 21(1): 135, 2019 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31801615
14.
Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients.
Breast Cancer Res
; 22(1): 2, 2019 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892336
15.
Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.
Br J Cancer
; 120(2): 247-255, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30563991
16.
Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach.
Breast Cancer Res Treat
; 175(2): 317-326, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796652
17.
Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer.
Mod Pathol
; 32(9): 1244-1256, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30976105
18.
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
Mod Pathol
; 32(1): 59-69, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30143750
19.
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
Histopathology
; 75(2): 225-235, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31017314
20.
Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.
Breast Cancer Res
; 20(1): 103, 2018 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30180877